Public Green, Private Gold: Opportunities from Climate Change Regulation in the U.S. and Mexico

By Gloria Park and Estuardo Anaya, Santamarina y Steta 

Global climate change is a very popular topic of discussion of late, both in Mexico and the United States, and particularly in California. Driven by a widely perceived consensus among scientists that global warming is currently taking place at an accelerating rate, due in large part to man-made carbon emissions, public opinion has impelled policy makers in both countries to take action. This article will compare the different approaches that Mexico and the U.S. are taking at various levels of government to address climate change issues, particularly through regulation of greenhouse gases (“GHGs”), and will analyze the resulting obstacles and opportunities for private enterprise in both countries.
 

Continue Reading...
Tags:

Implicit And Explicit Authority Of Corporate Representatives Differences Between Mexican And US Law

The scope of authority vested in an individual by virtue of his or her position in a US company can be as confusing and unfamiliar to a person from Mexico as the use of powers of attorney in Mexico is to someone from the US. A US person about to form a Mexican company will be asked at the outset to whom powers of attorney will be issued, and the nature of those powers. More often than not US clients will be baffled when these questions are first posed as they will not understand why powers of attorney are required at all, nor will they be familiar with the different forms of power of attorney. Conversely, a Mexican client about to form a US corporation will be just as perplexed when told by her attorney that no powers need be granted and that the officers and directors can perform all required functions by virtue of the authority inherent in their positions.

Continue Reading...

Moving Technology Across the Border: The Future of Biotech for the U.S. and Mexico

By Beni Surpin, Bram Hanono and Joseph Panetta, CEO, Biocom

Historically, the collaborative efforts between the U.S. and Mexico in the Biotech arena, separate from medical devices, have been at the educational level with informal collaboration projects and student exchanges. One of these, of course, initiated the founding of two well known biotechnology institutes in Mexico. In the late 1970's, a Mexican scientist named Francisco Bolivar participated in the development of the first genetically engineered protein and the development of the first cloning vectors at the University of California, San Francisco. He, along with Luis Herrera-Estrella, returned to Mexico to co-found and direct the Biotechnology Institute of the National Autonomous University of Mexico (UNAM) in Cuernavaca, and the Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV) in Irapuato. 
 

Continue Reading...